Dysregulation of mammalian target of rapamycin signaling in mouse models of autism

Kimberly M. Huber, Eric Klann, Mauro Costa-Mattioli, R. Suzanne Zukin

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.

Original languageEnglish (US)
Pages (from-to)13836
Number of pages1
JournalJournal of Neuroscience
Volume35
Issue number41
DOIs
StatePublished - Oct 14 2015

Fingerprint

Sirolimus
Autistic Disorder
Rett Syndrome
Fragile X Syndrome
Neuronal Plasticity
Tuberous Sclerosis
Neurofibromatosis 1
Autophagy
Morphogenesis
Phosphoric Monoester Hydrolases
Polymerization
Synapses
Actins
Spine
Cell Proliferation
Mutation
Genes
Autism Spectrum Disorder

Keywords

  • Fragile X syndromes
  • Mouse models of autism
  • MTOR signaling
  • Protein synthesis pathway

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Dysregulation of mammalian target of rapamycin signaling in mouse models of autism. / Huber, Kimberly M.; Klann, Eric; Costa-Mattioli, Mauro; Zukin, R. Suzanne.

In: Journal of Neuroscience, Vol. 35, No. 41, 14.10.2015, p. 13836.

Research output: Contribution to journalArticle

Huber, Kimberly M. ; Klann, Eric ; Costa-Mattioli, Mauro ; Zukin, R. Suzanne. / Dysregulation of mammalian target of rapamycin signaling in mouse models of autism. In: Journal of Neuroscience. 2015 ; Vol. 35, No. 41. pp. 13836.
@article{1721547043424858a10f440c4ce33669,
title = "Dysregulation of mammalian target of rapamycin signaling in mouse models of autism",
abstract = "The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.",
keywords = "Fragile X syndromes, Mouse models of autism, MTOR signaling, Protein synthesis pathway",
author = "Huber, {Kimberly M.} and Eric Klann and Mauro Costa-Mattioli and Zukin, {R. Suzanne}",
year = "2015",
month = "10",
day = "14",
doi = "10.1523/JNEUROSCI.2656-15.2015",
language = "English (US)",
volume = "35",
pages = "13836",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "41",

}

TY - JOUR

T1 - Dysregulation of mammalian target of rapamycin signaling in mouse models of autism

AU - Huber, Kimberly M.

AU - Klann, Eric

AU - Costa-Mattioli, Mauro

AU - Zukin, R. Suzanne

PY - 2015/10/14

Y1 - 2015/10/14

N2 - The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.

AB - The mammalian target of rapamycin (mTOR) is a central regulator of a diverse array of cellular processes, including cell growth, proliferation, autophagy, translation, and actin polymerization. Components of the mTOR cascade are present at synapses and influence synaptic plasticity and spine morphogenesis. A prevailing view is that the study of mTOR and its role in autism spectrum disorders (ASDs) will elucidate the molecular mechanisms by which mTOR regulates neuronal function under physiological and pathological conditions. Although many ASDs arise as a result of mutations in genes with multiple molecular functions, they appear to converge on common biological pathways that give rise to autism-relevant behaviors. Dysregulation of mTOR signaling has been identified as a phenotypic feature common to fragile X syndrome, tuberous sclerosis complex 1 and 2, neurofibromatosis 1, phosphatase and tensin homolog, and potentially Rett syndrome. Below are a summary of topics covered in a symposium that presents dysregulation of mTOR as a unifying theme in a subset of ASDs.

KW - Fragile X syndromes

KW - Mouse models of autism

KW - MTOR signaling

KW - Protein synthesis pathway

UR - http://www.scopus.com/inward/record.url?scp=84944531468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944531468&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.2656-15.2015

DO - 10.1523/JNEUROSCI.2656-15.2015

M3 - Article

C2 - 26468183

AN - SCOPUS:84944531468

VL - 35

SP - 13836

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 41

ER -